💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @FlashAlert_me | 14 |
| @InsiderAlerts4U | 12 |
| @Tickeron | 8 |
| @StockAlarms | 6 |
| @TradeWithAlerts | 5 |
Recent Tweets for EXEL
 |
@Xemadeyaka14 RT @ExelixisInc: Positive results from studies of $EXEL flagship therapy and @Roche #immunotherapy in #BladderCancer and #LungCancer just a… May 28th 2022, 11:05am |
|
@Xemadeyaka14 RT @ExelixisInc: Data from $EXEL flagship therapy in combination with an #immunotherapy in #HeadAndNeckCancer presented at #ASCO22. Learn m… May 28th 2022, 11:05am |
 |
@Tickeron $EXEL's 10-day Moving Average crossed below its 50-day Moving Average on May 10, 2022. View odds for this and other… https://t.co/L4k4D1zEVx May 28th 2022, 8:05am |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in EXELIXIS $EXEL https://t.co/upbWIMg1Qa May 28th 2022, 5:05am |
|
@Tickeron $EXEL enters a Downtrend because Momentum Indicator dropped below the 0 level on April 28, 2022. View odds for this… https://t.co/qkmzjr4fiI May 28th 2022, 3:05am |
|
@Tickeron How does this make you feel? $EXEL RSI Indicator left the oversold zone. #Exelixis #stockmarket #stock… https://t.co/xASAThEyTZ May 28th 2022, 2:05am |
 |
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director GEORGE POSTE: https://t.co/kZ4jrtwUnS May 28th 2022, 1:05am |
|
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director VINCENT T MARCHESI: https://t.co/F6ei9WHgic May 28th 2022, 1:05am |
|
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director STELIOS PAPADOPOULOS: https://t.co/Pi82Nja6p3 May 28th 2022, 1:05am |
 |
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director POSTE GEORGE: Granted 19,575 of Common Stock at price $0 on 2022-0… https://t.co/5hE0veTj33 May 28th 2022, 1:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director PAPADOPOULOS STELIOS: Granted 19,575 of Common Stock at price $0 o… https://t.co/yHggQNskuv May 28th 2022, 1:05am |
|
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director JACQUELINE WRIGHT: https://t.co/R8dwt9SimV May 28th 2022, 1:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director MARCHESI VINCENT T: Granted 19,575 of Common Stock at price $0 on… https://t.co/ml6nI38YDc May 28th 2022, 1:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director Smith Julie: Transacted Derivative Securities on 2022-05-26. https://t.co/aQAkz7d8lZ May 28th 2022, 1:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director Wright Jacqueline: Granted 10,180 of Common Stock at price $0 on 2… https://t.co/aJNaSRdZLC May 28th 2022, 1:05am |
|
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director MARIA C FREIRE: https://t.co/Rk05NjyjGE May 28th 2022, 12:05am |
|
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director LANCE WILLSEY: https://t.co/x3tvVh9CvT May 28th 2022, 12:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director WILLSEY LANCE: Transacted Derivative Securities on 2022-05-26. https://t.co/41tPZKe2oP May 28th 2022, 12:05am |
|
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director ALAN M GARBER: https://t.co/WKCf02AXDg May 28th 2022, 12:05am |
|
@InsiderAlerts4U $EXEL: New Insider Filing on EXELIXIS, INC.'s Director CARL B FELDBAUM: https://t.co/4ryvs7Mtsm May 28th 2022, 12:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director WYSZOMIERSKI JACK L: Granted 19,575 of Common Stock at price $0 on… https://t.co/YhWtVLPsr4 May 28th 2022, 12:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director Garber Alan M: Transacted Derivative Securities on 2022-05-26. https://t.co/nd00jELq8a May 28th 2022, 12:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director Freire Maria C: Granted 19,575 of Common Stock at price $0 on 2022… https://t.co/3GNvHYfB4U May 28th 2022, 12:05am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director FELDBAUM CARL B: Granted 10,180 of Common Stock at price $0 on 202… https://t.co/EgGcAPYNu9 May 28th 2022, 12:05am |
 |
@FintelAlerts Also, if you are new to $EXEL here's a background article on Finpedia for you https://t.co/nrIRe0rJtF May 27th 2022, 9:05pm |
 |
@investor_feed $EXEL 8-K Exelixis (27 May, 5:05pm) ? Departure of Directors or Certain Officers; Election of Directors… https://t.co/ueIBXS5dSP May 27th 2022, 9:05pm |
 |
@dailycandlestix $EXEL Rising Price, Declining Volume Daily appearances since 2010: 74 Close 5 days later ±: Avg: -0.01 SD: 1.22 Wor… https://t.co/8JsQKSKjHx May 27th 2022, 8:05pm |
 |
@TradeWithAlerts Nice print for $EXEL Size: 269321 Price: 18.4 Amount: $4,955,506.40 Time: 1600 See more: https://t.co/WzjaQRTmE4 Jo… https://t.co/IdqoxwITFn May 27th 2022, 8:05pm |
 |
@StockAlarms #BearishAlert Bearish Stock Alert: $EXEL at $18.24 This alert is meant for swing and day traders. For details, pl… https://t.co/x2d6WcpaeJ May 27th 2022, 5:05pm |
|
@StockAlarms #BearishAlert Bearish Stock Alert: $EXEL at $18.20 This alert is meant for swing and day traders. For details, pl… https://t.co/H6w81mbvsE May 27th 2022, 4:05pm |
 |
@hennry48288902 Entries & exits Daily! Discord link below? https://t.co/f0Vi4YdluV $EXEL May 27th 2022, 1:05pm |
 |
@MaisaCorp $EXEL Exelixis(EXEL) said late Thursday a phase 2 trial of cabozantinib in combination with pembrolizumab in patien… https://t.co/fnkvNSYpfX May 26th 2022, 11:05pm |
 |
@MarcJacksonLA $EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/YyBTHliKKs May 26th 2022, 9:05pm |
 |
@otcdynamics $EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/2MfV3gfSsq May 26th 2022, 9:05pm |
 |
@ExelixisInc Data from $EXEL flagship therapy in combination with an #immunotherapy in #HeadAndNeckCancer presented at #ASCO22.… https://t.co/j0Qh2GswHp May 26th 2022, 9:05pm |
|
@otcdynamics $EXEL Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients w… https://t.co/cnPTZg40Bp May 26th 2022, 9:05pm |
|
@ExelixisInc Positive results from studies of $EXEL flagship therapy and @Roche #immunotherapy in #BladderCancer and #LungCancer… https://t.co/RFNE2l1yHk May 26th 2022, 9:05pm |
 |
@StockNewsBot2 $EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/RINcfZ7Sn1 May 26th 2022, 9:05pm |
|
@StockNewsBot2 $EXEL Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients w… https://t.co/npa7geo9y0 May 26th 2022, 9:05pm |
 |
@FastestAlert $EXEL Exelixis Announces Detailed Results From Urothelial Carcinoma And Non-Small Cell Lung Cancer Cohorts Of The C… https://t.co/CgCbKT6SpF May 26th 2022, 9:05pm |
|
@FastestAlert $EXEL Exelixis Announces Results From Phase 2 Trial Of Cabozantinib In Combination With Pembrolizumab In Patients W… https://t.co/Nz7ght2qlC May 26th 2022, 9:05pm |
 |
@stock_titan $EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/uhQjHRqfpt May 26th 2022, 9:05pm |
|
@stock_titan $EXEL Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients w… https://t.co/6pFOWJ7lSw May 26th 2022, 9:05pm |
 |
@Thomas08127907 Entries & exits Daily! Discord link below? https://t.co/xZlWpQd5y4 $EXEL May 26th 2022, 8:05pm |
 |
@james73264347 .??. Alerts ? .??. Update ?? .??. Watchlist,?? .??. Discord link below ?? ? ? .*. https://t.co/LIQGUJ7HIG $EXEL May 26th 2022, 8:05pm |
 |
@paul12916846 Entries & exits Daily! Discord link below? https://t.co/NjgmbzuDtU $EXEL May 26th 2022, 8:05pm |
|
@StockAlarms #BearishAlert Bearish Stock Alert: $EXEL at $18.29 This alert is meant for swing and day traders. For details, pl… https://t.co/2q9hKZUiBR May 26th 2022, 7:05pm |
|
@hennry48288902 Entries & exits Daily! Discord link below? https://t.co/f0Vi4YdluV $EXEL May 26th 2022, 6:05pm |
 |
@datadili Exelixis, Inc. traded 121% above average volume, $EXEL closed up 0.62% May 26th 2022, 2:05am |
 |
@Daniel21911478 Alerts. ? Update ?? Watchlist,?? Discord link below ?? ? ? https://t.co/zgikneiovX $EXEL May 25th 2022, 6:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.